Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease

Authors

Konstantinos-Dionysios Alysandratos, Boston University
Jennifer A Wambach, Washington University School of Medicine in St. Louis
F Sessions Cole, Washington University School of Medicine in St. Louis
et al

Journal

Cell Reports

Publication Date

8-31-2021

Volume

36

Issue

9

First Page

109636

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2021.109636

Rights and Permissions

Alysandratos KD, Russo SJ, Petcherski A, Taddeo EP, Acín-Pérez R, Villacorta-Martin C, Jean JC, Mulugeta S, Rodriguez LR, Blum BC, Hekman RM, Hix OT, Minakin K, Vedaie M, Kook S, Tilston-Lunel AM, Varelas X, Wambach JA, Cole FS, Hamvas A, Young LR, Liesa M, Emili A, Guttentag SH, Shirihai OS, Beers MF, Kotton DN. Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease. Cell Rep. 2021 Aug 31;36(9):109636. doi:10.1016/j.celrep.2021.109636. Copyright 2021 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Alysandratos, Konstantinos-Dionysios; Wambach, Jennifer A; Cole, F Sessions; and et al, "Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease." Cell Reports. 36, 9. 109636 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10800